122 related articles for article (PubMed ID: 6124293)
21. SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile.
Angel I; Schoemaker H; Arbilla S; Galzin AM; Berry C; Niddam R; Pimoule C; Sevrin M; Wick A; Langer SZ
J Pharmacol Exp Ther; 1992 Dec; 263(3):1327-33. PubMed ID: 1281878
[TBL] [Abstract][Full Text] [Related]
22. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
Taouis M; Berlan M; Lafontan M
Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
[TBL] [Abstract][Full Text] [Related]
23. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Glusa E; Bevan J; Heptinstall S
Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on alpha-adrenoreceptor blocking activity.
Quaglia W; Brasili L; Cristalli G; Giardinà D; Picchio MT; Melchiorre C
J Med Chem; 1988 Sep; 31(9):1861-6. PubMed ID: 2900899
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of alpha 1s-adrenoceptors after exposure of the rat anococcygeus to benextramine.
Coates J; Weetman DF
Br J Pharmacol; 1983 Oct; 80(2):343-6. PubMed ID: 6140059
[TBL] [Abstract][Full Text] [Related]
26. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
27. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists.
Bond RA; Charlton KG; Clarke DE
J Pharmacol Exp Ther; 1986 Feb; 236(2):408-15. PubMed ID: 2868118
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the cardiac inotropic effect of phenylephrine by a tetramine disulfide with irreversible alpha-adrenoceptor blocking activity.
Benfey BG; Yong MS; Belleau B; Melchiorre C
Can J Physiol Pharmacol; 1979 May; 57(5):510-6. PubMed ID: 38001
[TBL] [Abstract][Full Text] [Related]
29. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.
Doxey JC; Smith CF; Walker JM
Br J Pharmacol; 1977 May; 60(1):91-6. PubMed ID: 18248
[TBL] [Abstract][Full Text] [Related]
30. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
Galitzky J; Mauriege P; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681
[TBL] [Abstract][Full Text] [Related]
31. Characterization of pigment aggregating alpha 2-adrenoceptors of fish melanophores by use of different agonists after partial irreversible receptor inactivation.
Karlsson JO; Andersson RG; Grundström N
Br J Pharmacol; 1989 May; 97(1):222-8. PubMed ID: 2566352
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by the tetramine disulphide, benextramine, of cardiac chronotropic histamine H2-receptor-mediated effects.
Belleau B; Benfey BG; Benfey TJ; Melchiorre C
Br J Pharmacol; 1982 Apr; 75(4):573-8. PubMed ID: 6121599
[TBL] [Abstract][Full Text] [Related]
33. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
Kimura Y; Okuda H
Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
[TBL] [Abstract][Full Text] [Related]
34. Support for a role for feedback regulation of norepinephrine release.
Kirpekar SM
Fed Proc; 1984 Apr; 43(5):1375-8. PubMed ID: 6142836
[TBL] [Abstract][Full Text] [Related]
35. The irreversible alpha-blocker benextramine interacts with two different thiol groups.
Melchiorre C; Gallucci P
Farmaco Sci; 1983 Dec; 38(12):950-6. PubMed ID: 6141952
[TBL] [Abstract][Full Text] [Related]
36. Epinephrine induces Ca2+ uptake in human blood platelets.
Owen NE; Feinberg H; Le Breton GC
Am J Physiol; 1980 Oct; 239(4):H483-H488. PubMed ID: 7425140
[TBL] [Abstract][Full Text] [Related]
37. Distribution and types of adrenoceptors in the guinea-pig ileum: the action of alpha- and beta-adrenoceptor blocking agents.
Bauer V
Br J Pharmacol; 1982 Aug; 76(4):569-78. PubMed ID: 6125224
[TBL] [Abstract][Full Text] [Related]
38. Reactivation by cysteamine of vascular alpha adrenoceptors blocked by the tetramine disulfide benextramine and interaction of benextramine with phenoxybenzamine.
Brasili L; Melchiorre C; Belleau B; Benfey BG
Can J Physiol Pharmacol; 1980 Dec; 58(12):1490-3. PubMed ID: 6263429
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of adrenaline-induced platelet aggregation by the orally administered alpha-adrenergic receptor blocker phentolamine (Regitine).
Pfister B; Imhof PR
Eur J Clin Pharmacol; 1977; 11(1):7-10. PubMed ID: 832661
[TBL] [Abstract][Full Text] [Related]
40. The effects of dopamine on human platelet aggregation, in vitro.
Braunstein KM; Sarji KE; Kleinfelder J; Schraibman HB; Colwell JA; Eurenius K
J Pharmacol Exp Ther; 1977 Feb; 200(2):449-57. PubMed ID: 839449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
